Purchases and Sales Made in Q4 2023 in Bio Xcel Therapeutics, Inc. (BTAI)
This table provides information about the institutional ownership of Bio Xcel Therapeutics, Inc. (BTAI) during Q4 2023. The information is specifically focused on institutions that hold shares of BioXcel Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-8.97K- 62.73% |
$20.8K - $49.4K
|
5.33K
$1.76K
|
|
|
Feb 14, 2024
Q4 2023
|
Engineers Gate Manager LP
New York, NY |
SELL
|
- |
-9.83K- 44.15% |
$22.8K - $54.2K
|
12.4K
$4.1K
|
|
|
Feb 15, 2024
Q4 2023
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-10.4K- 77.5% |
$24.1K - $57.1K
|
3.01K
$994
|
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-11.5K- 5.67% |
$26.7K - $63.5K
|
192K
$63.3K
|
|
|
Feb 13, 2024
Q4 2023
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-19.1K- 85.15% |
$44.4K - $106K
|
3.34K
$1.1K
|
|
|
Feb 09, 2024
Q4 2023
|
Citigroup Inc
|
SELL
|
- |
-21.4K- 88.12% |
$49.8K - $118K
|
2.89K
$954
|
|
|
Jan 23, 2024
Q4 2023
|
Davenport & CO LLC
|
SELL
|
- |
-26.1K- 42.47% |
$60.6K - $144K
|
35.4K
$11.7K
|
|
|
Feb 09, 2024
Q4 2023
|
Ubs Group Ag
|
SELL
|
- |
-30.3K- 38.53% |
$70.3K - $167K
|
48.3K
$15.9K
|
|
|
Feb 14, 2024
Q4 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-111K- 78.09% |
$257K - $610K
|
31K
$10.2K
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-114K- 85.55% |
$264K - $626K
|
19.2K
$6.34K
|
|
|
Feb 14, 2024
Q4 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-127K- 19.05% |
$295K - $701K
|
541K
$179K
|
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-131K- 10.74% |
$304K - $722K
|
1.09M
$360K
|
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-167K- 61.5% |
$387K - $918K
|
104K
$34.4K
|